Detalhe da pesquisa
1.
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blood
; 139(8): 1198-1207, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469514
2.
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies.
Br J Haematol
; 170(5): 669-78, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25942994
3.
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Biol Blood Marrow Transplant
; 20(11): 1813-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042735
4.
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
Ann Hematol
; 93(7): 1193-200, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24595733
5.
Emergence of central nervous system myeloma in the era of novel agents.
Hematol Oncol
; 30(4): 170-4, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22144117
6.
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
Br J Haematol
; 147(1): 83-8, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19694718
7.
All is not lost--the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.
Eur J Haematol
; 91(2): 189-90, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23668259
8.
Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine.
Eur J Haematol
; 87(2): 186-8, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21623918
9.
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
Leuk Lymphoma
; 57(5): 1044-53, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464106
10.
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
Am J Clin Pathol
; 123(4): 594-602, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15743747
11.
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.
Leuk Lymphoma
; 56(1): 49-56, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24724780
12.
New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers.
Front Oncol
; 3: 124, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23730625
13.
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.
J Clin Oncol
; 30(5): 488-96, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22184378
14.
Detection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia.
J Hematol Oncol
; 1: 10, 2008 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18664261
15.
No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
Leuk Lymphoma
; 53(7): 1420-2, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22204453
16.
Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.
Leuk Lymphoma
; 53(6): 1225-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22132874
17.
Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
Leuk Lymphoma
; 51(11): 1957-9, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20858101
18.
Genetics and molecular biology of chronic lymphocytic leukemia.
Curr Treat Options Oncol
; 6(3): 215-25, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15869733
19.
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.
J Natl Cancer Inst
; 97(23): 1781-5, 2005 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16333034
20.
Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.
Leuk Lymphoma
; 49(10): 1846-51, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18949607